Regenerative medicine is one of the great biomedical challenges of this century, seeking to regenerate parts of the human body throughout life lost to trauma, disease, or genetic factors. Real progress will hinge on our ability to combine effectively the frontiers of technology, biology, and clinical medicine to develop regenerative strategies. This Bioengineering Research Partnership (BRP), proposed by a team of seven investigators in the fields of neurology, surgery, endocrinology, materials science, chemistry, biomedical engineering, and chemical engineering, focuses on two specific challenges of great clinical importance, regeneration of the central nervous system (CNS) and cell replacement therapies for diabetic patients. In this application the target of the team is to develop multiple scaffold technologies and use CNS regeneration and pancreatic tissue replacement as their testing ground. The CNS targets include injection of self-assembling molecules and genetically engineered stem cells into the injured spinal cord or brain following stroke, and the diabetes targets include the development of a subcutaneous islet transplant. The four basic technologies are self-assembling nanofibers customizable to bear multiple tissue specific biological epitopes or have programmable delivery of growth factors; microporous biodegradable scaffolds that deliver genes or growth factors and guide cell migration; post-translationally modified recombinant polypeptides with customizable architecture and bioactivity; and enzyme-driven liquid-to-solid transitions of soluble bioactive peptides. The integrated scaffold technologies proposed include, the use of self-assembling nanofiber technology to modify microporous materials and create micro-nano hierarchical scaffolds, the adaptation of recombinant polypeptides for in situ enzyme driven solidification, and the development of bioactive two-phase molecular composite scaffolds containing linear polypeptides and peptide nanostructures.
| Edelbrock, Alexandra N; Àlvarez, Zaida; Simkin, Dina et al. (2018) Supramolecular Nanostructure Activates TrkB Receptor Signaling of Neuronal Cells by Mimicking Brain-Derived Neurotrophic Factor. Nano Lett 18:6237-6247 |
| Sato, Kohei; Hendricks, Mark P; Palmer, Liam C et al. (2018) Peptide supramolecular materials for therapeutics. Chem Soc Rev 47:7539-7551 |
| Motalleb, Reza; Berns, Eric J; Patel, Piyush et al. (2018) In vivo migration of endogenous brain progenitor cells guided by an injectable peptide amphiphile biomaterial. J Tissue Eng Regen Med 12:e2123-e2133 |
| Hendricks, Mark P; Sato, Kohei; Palmer, Liam C et al. (2017) Supramolecular Assembly of Peptide Amphiphiles. Acc Chem Res 50:2440-2448 |
| Berns, Eric J; Álvarez, Zaida; Goldberger, Joshua E et al. (2016) A tenascin-C mimetic peptide amphiphile nanofiber gel promotes neurite outgrowth and cell migration of neurosphere-derived cells. Acta Biomater 37:50-8 |
| Pazos, Elena; Sleep, Eduard; Rubert Pérez, Charles M et al. (2016) Nucleation and Growth of Ordered Arrays of Silver Nanoparticles on Peptide Nanofibers: Hybrid Nanostructures with Antimicrobial Properties. J Am Chem Soc 138:5507-10 |
| Skoumal, Michael; Seidlits, Stephanie; Shin, Seungjin et al. (2016) Localized lentivirus delivery via peptide interactions. Biotechnol Bioeng 113:2033-40 |
| Newcomb, Christina J; Sur, Shantanu; Lee, Sungsoo S et al. (2016) Supramolecular Nanofibers Enhance Growth Factor Signaling by Increasing Lipid Raft Mobility. Nano Lett 16:3042-50 |
| Stephanopoulos, Nicholas; Freeman, Ronit; North, Hilary A et al. (2015) Bioactive DNA-peptide nanotubes enhance the differentiation of neural stem cells into neurons. Nano Lett 15:603-9 |
| Rubert Pérez, Charles M; Stephanopoulos, Nicholas; Sur, Shantanu et al. (2015) The powerful functions of peptide-based bioactive matrices for regenerative medicine. Ann Biomed Eng 43:501-14 |
Showing the most recent 10 out of 140 publications
